⚡ D1/D2 Dopamine Agonist — Central Signal

Apomorphine

Initiates the erection signal from the brain — the "top-down" approach for cases where blood-flow compounds alone haven't been enough. This is MELTS' rescue compound for refractory ED.
Clinician-gated: Apomorphine is only available in S8 Quantum. Q1 tier is accessible via Cynthia AI intake (with appropriate clinical flags); Q2 tier requires explicit clinician escalation.
Onset
15 min
Sublingual delivery
Half-life
40-60 min
Peak: ~45 min
Max Dose
6 mg
MELTS: 3 mg
Status
503A
Compounded
⚙️ How It Works
💊

Sublingual Absorption

Apomorphine dissolves under the tongue and reaches the brain rapidly. Sublingual route avoids the intense nausea that occurs with oral/injectable forms.

🧠

D1/D2 Receptors Activate

Apomorphine stimulates dopamine D1 and D2 receptors in the paraventricular nucleus (PVN) of the hypothalamus — the brain's erectile control center.

💜

Oxytocin Release Triggered

The dopaminergic activation triggers endogenous oxytocin release from the PVN. This is the brain's natural "erection initiation" pathway.

🔌

Spinal Cord Signal

The combined dopamine-oxytocin signal travels down the spinal cord to the sacral erection center, initiating the "top-down" erectile reflex.

Central Erection + PDE5i Synergy

The central signal combines with PDE5 inhibitors (vardenafil/tadalafil in S8) for triple-mechanism coverage: brain signal + blood flow + smooth muscle relaxation.

📦 Which Stacks Contain Apomorphine
S8 Quantum
When standard isn't enough
Q1 (AI-gated)3 mg
Q2 (Clinician)3 mg + OT
📋 Considerations

⚠️ Common — requires first-dose precautions

  • Nausea (30-40%) — most common, typically mild
  • Dizziness — take first dose sitting or lying down
  • Yawning — unusual but well-documented dopaminergic effect
  • Headache

🔴 Critical safety

  • Fainting risk (syncope) — report any episode immediately
  • No alcohol within 4 hours
  • First dose must be supervised or taken sitting/lying
  • QTc prolongation risk — ECG screening recommended
Drug Interactions
Medication ClassSeverityWhat Happens
Ondansetron (Zofran)🔴 BLOCKSevere hypotension and loss of consciousness. Absolute contraindication.
Nitrates🔴 BLOCKCombined PDE5i + apomorphine in S8 means nitrate contraindication applies.
Alcohol🟡 AVOIDAdditive CNS depression + hypotension. No alcohol 4 hours before/after.
Antipsychotics🟡 ADJUSTDopamine antagonists may blunt apomorphine's effect. Clinical review needed.
QTc-prolonging drugs🟡 MONITORAdditive QTc risk. Monitor if on other QTc-prolonging medications.
Common Questions
Is apomorphine related to morphine?
No. Despite the similar name, apomorphine is NOT an opioid and has zero addictive potential. It's a dopamine agonist derived from the same chemical family but with completely different pharmacology. It doesn't cause sedation or euphoria.
Why is this only in S8 Quantum?
Apomorphine's side effect profile (nausea, dizziness, fainting risk) means it's reserved for cases where simpler options haven't worked. S8 Quantum is our rescue stack for PDE5 inhibitor non-responders — members who've tried S1-S4 without adequate results. It adds a third mechanism of action on top of PDE5 inhibition.
What about the fainting risk?
Syncope (fainting) occurs in about 3-5% of users, usually with the first dose. This is why we recommend taking the first dose sitting or lying down in a safe environment, with no alcohol. The risk decreases significantly with subsequent doses as your body adjusts.
← Back to Compound Library